Sageworth Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History

Sageworth Trust’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13	Closed	-$1K	–	292
2018 Q4	$1K	Buy	+13	New	+$787	﹤0.01%	160

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Sageworth Trust's PPH Position: Q1 2019 in Review

Sageworth Trust sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2019, closing a stake of 13 shares — an estimated $1K sold.

Sageworth Trust first reported a position in PPH in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 46 funds tracked by Wall St. Rank hold PPH as of Q1 2019.

Sageworth Trust reported no remaining VanEck Pharmaceutical ETF position as of Q1 2019 after selling out during the quarter.
Sageworth Trust sold 13 VanEck Pharmaceutical ETF shares in Q1 2019, an estimated $1K.
Sageworth Trust first reported a position in VanEck Pharmaceutical ETF in Q4 2018 and held it in 1 quarter.
Sageworth Trust's VanEck Pharmaceutical ETF position peaked at $1K in Q4 2018.
46 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2019.

Based on Sageworth Trust's 13F filing for Q1 2019, filed 8 Apr 2019.